Opioid Use Disorder
On October 25, 2019, an amended application for authorization to institute a class action was filed. The purpose of the amendments is to replace the plaintiff EV with the new plaintiff Mr. Camarda, remove certain defendants, add other defendants and amend the class definition.
On May 23, 2019, EV filed a motion for authorization to institute a class action against the manufacturers, marketers or distributors of opioid drugs, including fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone and oxymorphone. She is represented by TJL as well as Fishman Flanz Meland Paquin in this file.
This application was amended on October 25, 2019 to replace the plaintiff EV with Mr. Camarda, remove certain defendants, add other defendants and amend the class definition.
The class action seeks to compensate every person who suffers or has suffered from opioid use disorder following the use of prescription opioids.
Opioids are a class of drugs which resemble naturally occurring opiates that are prescribed to treat pain. However, these drugs are dangerously addictive, and the growing number of addictions, overdoses and deaths in Quebec and Canada caused by opioids has been declared by the Government of Canada to be a public health emergency.
Are you a class member?
The class is defined as follows in the motion seeking authorization:
All persons in Quebec who have been prescribed and consumed any one or more of the opioids manufactured, marketed, distributed and/or sold by the Defendants between 1996 and the present day (“Class Period”) and who suffer or have suffered from Opioid Use Disorder, according to the diagnostic criteria herein described.
The Class includes the direct heirs of any deceased persons who met the above-mentioned description.
The Class excludes any person’s claim, or any portion thereof, subject to the settlement agreement entered into in the court file no. 200-06-000080-070, provided that such settlement agreement becomes effective as a result of the issuance of the requisite court approvals.
If you are a member of this class action and wish to receive information about its progress, you can sign up to our mailing list by filling out the form at the bottom of the page.